What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His scientific interests lie mostly in COPD, Internal medicine, Physical therapy, Pulmonary disease and Respiratory disease.
The study incorporates disciplines such as Anesthesia, Exacerbation, Randomized controlled trial, Intensive care medicine and Placebo in addition to COPD.
He has researched Internal medicine in several fields, including Endocrinology, Surgery and Cardiology.
His Cardiology study incorporates themes from Respiratory minute volume and Lung disease.
Pulmonary rehabilitation is the focus of his Physical therapy research.
His Respiratory disease research is multidisciplinary, incorporating elements of Inflammation and Wasting.
His most cited work include:
- American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation (1460 citations)
- Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease: A Disease-Specific Self-management Intervention (816 citations)
- Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. (675 citations)
What are the main themes of his work throughout his whole career to date?
COPD, Internal medicine, Physical therapy, Pulmonary disease and Cardiology are his primary areas of study.
François Maltais interconnects Anesthesia, Placebo, Randomized controlled trial and Intensive care medicine in the investigation of issues within COPD.
His studies deal with areas such as Endocrinology and Surgery as well as Internal medicine.
His Physical therapy research is multidisciplinary, incorporating perspectives in Quality of life and Physical medicine and rehabilitation.
His Pulmonary disease study frequently involves adjacent topics like Pathology.
His Cardiology study combines topics from a wide range of disciplines, such as VO2 max, Breathing, Inspiratory Capacity, Cardiorespiratory fitness and Dynamic hyperinflation.
He most often published in these fields:
- COPD (66.86%)
- Internal medicine (43.27%)
- Physical therapy (35.09%)
What were the highlights of his more recent work (between 2018-2021)?
- COPD (66.86%)
- Internal medicine (43.27%)
- Pulmonary disease (22.81%)
In recent papers he was focusing on the following fields of study:
François Maltais mainly investigates COPD, Internal medicine, Pulmonary disease, In patient and Cardiology.
His COPD research includes elements of Vilanterol, Exacerbation, Randomized controlled trial, Post-hoc analysis and Physical therapy.
His Physical therapy study integrates concerns from other disciplines, such as Olodaterol, Placebo, Quality of life and Disease.
His Pulmonary disease research incorporates themes from Anesthesia, Crossover study, Physical medicine and rehabilitation, Multicenter study and Intensive care medicine.
His work is dedicated to discovering how Intensive care medicine, Chronic respiratory failure are connected with Pulmonary rehabilitation and other disciplines.
Within one scientific family, François Maltais focuses on topics pertaining to Cardiorespiratory fitness under Cardiology, and may sometimes address concerns connected to Heart rate.
Between 2018 and 2021, his most popular works were:
- Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial (19 citations)
- Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence (16 citations)
- Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study. (16 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
François Maltais spends much of his time researching COPD, Internal medicine, Pulmonary disease, Cardiology and Physical therapy.
François Maltais has included themes like Olodaterol, Exacerbation, Randomized controlled trial, Quality of life and Anxiety in his COPD study.
His research integrates issues of Lung cancer and Clinical trial in his study of Quality of life.
His research in Pulmonary disease focuses on subjects like Intensive care medicine, which are connected to Pharmacological therapy, Pharmacotherapy, Atrophy, Muscle mass and Limb muscle.
His Cardiology research includes themes of Cardiorespiratory fitness and Sit to stand test.
His biological study spans a wide range of topics, including Regimen, Adverse effect, Disease and Protocol.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
